Trial Information

Summary: Clinical Trial to evaluate the effectiveness of investigational medication for the treatment of Osteoarthritis and Rheumatoid Arthritis.

Phase IV,Double-Blind, Parallel-Group study of Cardiovascular safety in Osteoarthritis or Rheumatoid Arthritis Patients with or at High Risk for Cardiovascular Disease comparing Celecoxib with Naproxen and Ibuprofen

Patient Inclusion Criteria

• Men or Women 18 yrs or older
• Diagnosis of Osteoarthritis or Rheumatoid Arthritis of at least 6 months
• Must be eligible for chronic daily therapy with an NSAID to control symptoms
• Subject with established or at high risk for Cardiovascular Disease

Patient Exclusion Criteria

• Has acute joint trauma with symptoms
• Planned surgery or invasive procedure
• Known hypersensitivity to celecoxib, ibuprofen, naproxen, aspirin, esomeprazole, sulfonamides, proton pump inhibitors, lactose or NSAIDS
• Malignancy within the last 5 years
• GI disorders

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:07 AM